Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02642640 · ClinicalTrials.gov registry record · NA
Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02642640 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 23 participants.
The verdict
NCT02642640, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This project aims to test the impact of melatonin and MTNR1B variation on regulation glucose regulation in a highly controlled in-laboratory setting and ex vivo in pancreatic islets.
Interventions
- DRUG placebo
- DIETARY_SUPPLEMENT melatonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-11 |
| Est. Completion | 2022-03-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02642640
The ClinicalTrials.gov registry entry for NCT02642640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02642640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02642640 about?
NCT02642640 is a clinical study titled "Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1". This project aims to test the impact of melatonin and MTNR1B variation on regulation glucose regulation in a highly controlled in-laboratory setting and ex vivo in pancreatic islets.
What is the current status of trial NCT02642640?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-11. Estimated completion is 2022-03-24.
What interventions are being tested in trial NCT02642640?
The interventions under investigation include: placebo (DRUG), melatonin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02642640?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.